相关实验视频

Updated: Jan 15, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

患有持续正常转氨基酶的患者中孤立的IgG升高不会影响自身免疫性肝炎的结果

Álvaro Díaz-González¹, Ida Schregel^2,3, Lorena Carballo⁴

¹Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases Group, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain.

JHEP reports : innovation in hepatology

|October 16, 2025

概括

持续高的免疫球蛋白G (IgG) 水平不会使自身免疫性肝炎患者的纤维化或肝硬化恶化. 这一发现挑战了目前对完整生化反应的定义,表明转氨酶正常化是治疗的关键终点.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
胃肠病学胃肠病学

背景情况:

自身免疫性肝炎 (AIH) 治疗的目标是生物化学反应,包括正常化的转氨酶和免疫球蛋白G (IgG).
最近的研究质疑正常化IgG水平对生存的影响.
持续升高的IgG或IgG爆发对AIH中的纤维化和肝硬化的影响尚不清楚,尤其是在正常的转氨基酶.

研究的目的:

评估持续升高的IgG水平 (IgGe) 和IgG爆发 (IgGf) 对AIH患者纤维化进展和肝硬化发展的影响.
评估高IgG是否会影响AIH患者达到正常转氨酶水平的结果.

主要方法:

对493名AIH患者进行了回顾性多中心队列研究,这些患者持续正常的转氨基酶.
使用治疗权重的逆概率 (IPTW) 来平衡队列.
随访时间中位数为6.2年.

主要成果:

升高的IgG (IgGe或IgGf) 在IPTW后没有显著影响纤维化进展 (p=0.275) 或肝硬化发展 (p=0.211).
转氨酶正常化时的肝硬度测量 (LSM) 是肝硬化发展的唯一独立预测因素 (HR 1.30,p<0.001).
诊断时肝硬化的预测因素包括年龄,白蛋白,IgG和血小板计数.

结论:

持续或暂时的血清IgG升高不会显著影响正常转氨基酶患者的AIH疾病进展.
这些发现挑战了目前对AIH完整生化反应的定义.
转氨酶水平的正常化似乎是最关键的治疗终点.

关键词:

自体免疫性肝炎是一种自身免疫性肝炎.完整的生化反应反应.免疫球蛋白G是一种免疫球蛋白.

更多相关视频

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...